BioSpace News Archive

The increasing number of unwanted pregnancies across the globe requires a solution in the form of contraceptive measures.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global kidney cancer diagnostics market is expected to reach a valuation of US$ 1.2 Bn, registering a CAGR of 7% during the forecast period.

Alterity Therapeutics Limited, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 September 2021.

Affimed N.V., a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it will release third quarter 2021 results on Wednesday, November 10, 2021, and host a conference call at 8:30 a.m. EST to discuss financial results and recent corporate developments.

Neurologist Dr. John Michael Olichney to discuss utility of P300 to assess cognitive function Webinar to be held Friday, Nov. 5, at 9 a.m. PT / 12 p.m. ET

New offering expands Pfizer’s growth hormone portfolio of medicines and treatment options for rare diseases

Alkermes plc (Nasdaq: ALKS) today announced plans to present research from its psychiatry and addiction portfolios at upcoming scientific conferences this fall.

World Psoriasis Day: AxisBiotix-Ps ™ , Food Supplement Targeting Psoriasis Symptoms Launches Today

Oramed Pharmaceuticals Inc. today announced that its majority-owned subsidiary, Oravax Medical Inc. ( www.ora-vax.com ), has received clearance from the South African Health Products Regulatory Authority to commence patient enrollment in a first in human, Phase 1 clinical trial, for its oral COVID-19 vaccine and preparations to begin the trials are now underway.

Rapid Micro Biosystems, Inc. today announced that it will be participating in the Stifel 2021 Virtual Healthcare Conference on Tuesday, November 16, 2021.